Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the third ...

Although not designed to eliminate experiments, the model, which is intended to accelerate process development, can reduce the number needed.

Tissues consist of a heterogeneous mixture of different cell types, complicating our understanding of their biological ...

A study published in the Journal of Medicinal Chemistry presents a new family of candidate compounds for the treatment of ...